+38 (095) 926-25-85
Trichocosmetics

Biological foundations of hair follicle ageing

Ovcharenko Yu.S. Biological foundations of hair follicle ageing // Трихология. – ИД «Косметика и медицина». – Moscow, (1) 2016 – pp. 28-40 (original in Russian).

Hair is considered one of the most important factors in attractiveness, yet, like the skin and the body as a whole, it is subject to ageing. The nature of the hair follicle holds many mysteries, and it is now being actively studied in search of effective anti-ageing methods for use in trichology. Among the many approaches, specialists pay close attention to hormone replacement therapy, on the assumption that the gradual decline and imbalance of hormones with age are closely linked to the ageing process. With this article we begin a series of publications on this subject, and we propose to start with the basics: the gerontobiology of the hair follicle, that is, the patterns of its ageing.

Together with epidermal pigmentation, the mini-organ that produces the hair fibre accounts for most of the phenotypic variation between different human subpopulations. The hair follicle performs several important functions: thermal insulation, camouflage, social and sexual communication, sensory perception and protection against injury, harmful influences, insects and so on. However, the biological significance of hair bears no comparison with its social and psychological significance for people. Hair is one of the most important aspects of physical attractiveness [1]. Psychological concern about hair is growing even stronger today, as longer life expectancy inevitably fuels our wish to prolong youth. Concern about the density of hair fibres, their texture, length and colour drives the relentless growth of the hair care market, whose worldwide share already runs to billions of euros (Euromonitor data).

Because of our relative nakedness, the subject of study and of the greatest attention (whether scientific or commercial) is scalp hair, which only in primates can be very dense, very long and very heavily pigmented. Scientists studying the biology of hair growth and pigmentation have shown that the hair follicle (HF) is an extremely accessible and unique model for gerontologists, offering unrivalled opportunities to study age-related changes [2].

Scientists in many fields have focused on the multipotent stem cells of the HF. Studies have shown that all the epithelial layers of the follicle and the hair are formed by bulge cells. Understanding the role of the types of stem cells in the hair follicle is a promising approach to studying hair growth and ageing. R. Hoffman, professor of biology at the University of California, San Diego, reported the results of his research on stem cell markers, named Nestin. Hoffman found them in abundance in human hair follicles. In vitro these cells can differentiate into neurons, glial cells, keratinocytes, smooth muscle cells and melanocytes, and in time they may become an accessible source of adult stem cells for creating new organs and treating a wide range of diseases [3]. All of the above determined the theme of this series of publications, which will review the aspects of hair ageing, with articles on its biological foundations as well as on current concepts of diagnosing, treating and preventing hair ageing.

Hair ageing: the main aspects

The study of hair ageing concentrates on two main areas of research: the aesthetic aspect of hair ageing and its control, and the biological aspect of hair ageing through the lens of microscopic, biochemical and molecular changes. Hair ageing consists of ageing of the hair shaft and ageing of the hair follicle: the first includes weathering and photoageing, while the second shows as a decline in melanocyte function (greying) and reduced hair production (alopecia). The scalp and hair undergo intrinsic, or physiological, ageing and extrinsic, or premature, ageing under the influence of external factors. Intrinsic factors are linked to individual genetic and epigenetic mechanisms with inter-individual variability, including the gerontobiology of the HF, the genetics of premature familial greying, androgen metabolism in androgenetic alopecia (AGA), the oxidative metabolism of melanogenesis and multimorbid conditions. Among the external factors involved in ageing of the skin and hair, ultraviolet radiation and smoking have been studied. Experimental data support the hypothesis that oxidative stress plays an active part in the ageing of skin and hair. Ageing of the hair shaft is caused by photoageing [4].

The role of multimorbid conditions that are typical of older patients and affect the hair deserves attention: endocrine disorders, nutritional deficiencies, psychological disorders and adverse drug effects, and dermatoses. The growing number of chronic diseases in the population points to the need for a comprehensive approach to treating hair problems in older people and for taking seriously the possibility that a general health problem underlies the patient's complaint.

Follicular cell subpopulations show the processes that drive ageing in general, for example oxidative damage, telomere shortening, age-related deficits in nuclear/mitochondrial DNA damage and repair, and an age-related decline in cellular energy supply [2]. This article will focus on how the gerontobiology of the HF affects certain aspects of the hair fibre phenotype, and will also discuss endocrine status and its effect on hair.

Gerontobiology of the hair follicle

The HF is a true histological mélange of several cell types (epithelial, mesenchymal and neuroectodermal) that function simultaneously at every stage of their existence – for example, stem cells, transit-amplifying cells and terminally differentiated cells [5]. The HF is also unique in that it follows a strictly regulated scenario of multiple lifelong cycles of cell birth, proliferation, differentiation and death. Effective evolutionary selection has robustly programmed the HF against any significant age-related loss of function, even after 12 or more decades of life.

Transformation of hair follicle types

All HFs form during embryonic development, and no additional follicles are formed in humans after birth. At birth a person has between two and five million vellus and terminal hair follicles. There is a wealth of clinical evidence on the transformation of the different forms of hair fibre produced by a single human follicle over a person's life, both in health and in disease. Normally the HF produces several different types of hair fibre during its lifetime: fine unpigmented lanugo hair in the foetus, short (mostly unpigmented) vellus hair or fine pigmented intermediate hair in childhood, and long thick terminal hair on several areas of the body in adults. It should be stressed that the change in the form of the hair fibre, from relatively long and variably pigmented hair (lanugo) before birth, to almost invisible colourless fibres (vellus) after it, and on to coarse terminal hair of phenomenal length, all happens in one and the same HF.

At puberty, vellus hair in some areas of the body is replaced by longer, coarser, pigmented terminal hair. Hair growth begins in the pubic area, and the eyelashes and eyebrows become thicker than before puberty. Axillary hair and facial hair in men begin to appear about two years after pubic hair growth starts. Body and facial hair continue to grow after puberty; their growth is stimulated by male hormones, which, paradoxically, in androgenetic alopecia can also cause terminal hair follicles on the scalp to revert to vellus hair. These transformations can happen rapidly and reflect a puberty-related change in hair phenotype. The likelihood of androgen-induced terminal hair growth on areas of the body varies with age, sex and ethnicity. Several studies have contributed to a consensus that HF miniaturisation with age most probably occurs through relatively abrupt reductions in the number of cells of the dermal papilla and/or the dermal sheath, both during and between individual hair growth cycles [6].

In adults the hair fibre can also transform back from vellus into lanugo hair. For example, acquired hypertrichosis lanuginosa may be associated with an underlying neoplasm [7]. Renewed growth of lanugo hair on the body is also one of several dermatological signs in patients with eating disorders. Hypertrichosis on certain areas of the body may appear with age in both men and women, for example terminal hair growth on the upper lip and chin in postmenopausal women, and on the ears, in the nose and the nasal passages in ageing men [9].

Ageing is also associated with a shorter period of active hair growth and a smaller shaft diameter, most marked in thick hairs. The kenogen phase of the hair cycle lasts longer. These changes, though less pronounced, resemble those seen in male pattern baldness [9]

Studies of hair in postmenopausal women compared with women of reproductive age showed significant changes, mainly in the frontal hair-bearing area. These changes include a lower proportion of anagen hairs, a slower growth rate and a smaller hair diameter in the frontal area [4].

Age-related changes in hair pigmentation

Hair colour is a clear indicator of age-related change, especially in people of European descent. At puberty, light “intermediate” hair is often replaced by darker, coarser “terminal” hair. Follicular melanin has an internal “biological clock”, and greying heralds inevitable ageing. Every decade after the age of 30, the number of pigment-producing melanocytes in the epidermis falls by 10–20%.

The age at which greying begins is genetically controlled and inherited. By a rough estimate, by the age of 50, 50% of people have 50% grey hair. Grey hair spreads more widely on dark hair than on fair hair; it usually appears first at the temples and moves towards the crown, then spreads to the rest of the head, reaching the occiput last. The beard and body hair usually turn grey later. Greying spreads in waves, slowly, from the crown to the occiput [10].

The reduced pigmentation of scalp hair in male pattern baldness is linked to the smaller hair diameter. This is thought to result largely from the reduced capacity of smaller, finer hairs to accommodate a large number of melanocytes. Such “miniaturised” hairs also have a smaller medulla than terminal hairs.

There is evidence that the mechanical properties of grey and white hair fibres differ from those of neighbouring pigmented hairs. Hollfelder presented evidence that hair without pigment, unlike pigmented hair, may be not only coarser but also wavier [11]. Other authors have also reported that the mean diameter of recently greyed fibres is significantly larger than that of pigmented ones. The same study reported a more developed medulla in white hair fibres compared with pigmented ones [12]. Interestingly, these researchers also described an age-related decline in hair growth rate and hair fibre diameter, but only for pigmented hair. So, strange as it may seem, some age-related changes may partly spare the “older” white hairs.


Diagnosis and treatment at the Institute

Get a consultation

How age affects some phenotypic properties of hair


While the obvious phenotypic features include thinning and loss of hair, a slower growth rate and loss of pigmentation [13], ageing can also change the surface morphology of the hair, seen both as smaller cuticle scales and as a lack of moisture in the hair fibre. According to available data, a lack of moisture and lipids in the hair shaft is seen with increasing age, especially in women. Sebaceous gland activity varies considerably with sex and age: relatively dormant before puberty, the gland becomes very active in adolescence and early adulthood, and its activity falls markedly after the fourth decade of life, above all in women. Besides the obvious overall changes in the size and activity of the gland, more subtle ones include a change in the composition of the lipids it produces at different periods of our life. For example, children's sebum contains less squalene and cholesterol than that of adults [14].

A study of how ageing affects the integrity of the cell membrane complex, which helps cortical cells hold together in the fully keratinised hair, found a small but statistically significant rise in cholesterol concentration with increasing age; it was therefore suggested that these data reflect changes in keratinisation with age and that the finding is probably a biomarker of ageing [4].

Just as the lipid composition of human sebum changes with age, there is an age-related change in the chemical composition of hair fibres. Decreases in glutathione reductase, glutathione S-transferase, glucose-6-phosphate dehydrogenase and gamma-glutamyl transpeptidase have been recorded [15].

A Raman spectroscopy study of age-related changes in the internal structure of the hair fibre showed a decrease in cystine disulphide (-SS-) in the hair cortex [16]. Analysis of so-called blocked anagen follicles on the scalp showed that natural (true) ageing, characterised by progressive wear of the cuticle from the roots to the tips of the hair fibres, was also accompanied by lower levels of ceramides and 18-methyleicosanoic acid, as well as of protein subfamilies belonging to the keratin group (ultra-high-sulphur, high-sulphur and high-glycine-tyrosine proteins). A progressive decline in the mechanical strength of these long hair fibres was also noted [17].

Summary

The hair follicle is a mini-organ whose nature holds no fewer mysteries than the nature of human thought. Current areas of research and potential therapeutic approaches include stem cells of follicular origin and techniques for culturing hair follicle tissue.

Age-related hair problems include involutional alopecia, androgenetic alopecia, greying and weathering of the hair. In an older patient, however, hair loss may be caused by medications, surgery, metabolic disorders, inflammatory processes, genetic predisposition or a combination of these. Hair ageing can also be a cosmetic problem, as the hair becomes fine, fragile, dry and brittle. Atrophic changes and fibrosis can also be found on the ageing scalp. 

Anti-ageing medicine seeks and applies treatments aimed at modifying, easing or slowing conditions that progress with age. Among the many approaches, specialists pay close attention to hormone replacement therapy, on the assumption that the gradual decline and imbalance of hormones with age are closely linked to the ageing process. 

The rapid development of trichology is driving the refinement of diagnostic algorithms and the emergence of new anti-ageing treatment protocols, which will be discussed in later publications of this series.

References

  1. Злотогорский А., Шапиро Д. [и др.]. Трихология / под ред. А. Литуса; пер. с англ. Ю. Овчаренко. – К.: Рудь, 2013. – 160 с., ил.
  2. Trueb R. M. Aging of hair // J Cosmet Dermatol. – 2005, 4: 60–72.
  3. Li L., Mignone J., Yang M., Matic M., Penman S., Enikolopov G., Hoffman R. M. Nestin expression in hair follicle sheath progenitor cells // Proc Natl Acad Sci. – 2003.– USA 100: 9 958–9 961.
  4. Ralph M. Trüeb. Desmond J. Tobin (Eds.) Aging Hair — Springer. – 2010: 270.
  5. Trüeb R. M. Hormone und Haarwachstum // Hautarzt. — 2010, 61: 487–95.
  6. Whiting DA Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss // J Am Acad Dermatol. — 2001, 45: 81–86.
  7. Chung V. Q., Moschella S. L., Zembowicz A., Liu V. Clinical and pathologic findings of paraneoplastic dermatoses // J Am Acad Dermatol. — 2006, 54: 745–762.
  8. Wendelin D. S., Pope D. N., Mallory S. B. Hypertrichosis // J Am Acad Dermatol . — 2003, 48(2): 161–179.
  9. Courtois M., Loussouarn G., Hourseau C., Grollier J. F. Ageing and hair cycles // Br J Dermatol. – 1995, 132: 86–93.
  10. Blume-Peytavi U., Tosti A., Whiting D. A., eds. Hair Growth and Disorders // Berlin Heidelberg: Springer-Verla. – 2008: 1-71.
  11. Hollfelder B., lankenburg G., Wolfram L. J., Hцcker H. Chemical and physical properties of pigmented and nonpigmented hair (gray hair) // Int J Cosmet Sci.– 1995, 17: 87–89. 
  12. Van Neste D., Tobin D. J. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging // Micron. - 2004, 35 (3): 193–200.
  13. Van Neste D. Thickness, medullation and growth rate of female scalp hair are subject to significant variation according to pigmentation and scalp location during ageing // Eur J Dermatol.- 2004, 14: 28–32.
  14. Zouboulis C. C., Boschnakow A. Chronological ageing and photoaging of the human sebaceous gland // Clin Exp Dermatol.- 2001, 26(7): 600–607.
  15. Kermici M., Pruche F., Roguet R., Prunieras M. Evidence for an age-correlated change in glutathione metabolism enzyme activities in human hair follicle // Mech Ageing Dev. – 1990, 53(1): 73–84.
  16. Kuzuhara A., Fujiwara N., Hori T. Analysis of internal structure changes in black human hair keratin fibers with aging using Raman spectroscopy // Biopolymers. – 2007, 87 (2–3): 134–140.
  17. Silberzan I., Thibaut S., de Becker E., et al. Chronological ageing of human hair keratin fibers // Int J of Cosmet Sci (inpress). – 2010
  18. Hamilton J. B. Age, sex and genetic factors in the regulation of hair growth in man: a comparison of Caucasian and Japanese populations. In: Montagna W, Ellis RA (eds) // The biology of hair growth. Academic Press, New York. – 1958. Р. 399–433.
  19. Ткачев В.П. Нейроэндокринная регуляция роста волос 
  20. Phillips T. J., Demarcay Z., Sahu M. Hormonal effects on skin aging // Clin Geriatr Med. – 2001. – 17: 661–672.
  21. Lynfield Y. L. Effect of pregnancy on the human hair cycle // J Invest Dermatol. – 1960. –35: 323–327.
  22. Riedel-Baima B., Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio // Endocr. Regul. – 2008. – 42 (1): 13–16.
  23. Carlini P., Di Cosimo S., Ferretti G., Papaldo P., Fabi A., Ruggeri E. M., Milella M., Cognetti F. Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin // Ann Oncol. –2003. – 14 (11): 1 689–1 690.
  24. Venning V. A., Dawber R. P. Patterned androgenetic alopecia in women // J Am Acad Dermatol. –1988. – 18: 1 073–1 077.
  25. Thornton M. J. The biological actions of estrogens on skin // Exp Dermatol. – 2002. – 11 (6): 487–502.
  26. Ohnemus U., Uenalan M., Conrad F., Handjiski B., Mecklenburg L., Nakamura M., Inzunza J., Gustafsson J. A., Paus R. Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling // Endocrinology. – 2005. – 146 (3): 1 214–1 225.
  27. Billoni N., Buan B., Gautier B., Gaillard O., Mahі Y. F., Bernard B. A. Thyroid hormone receptor beta1 is expressed in the human hair follicle // Br J Dermatol. – 2000. – 142 (4): 645–652.
  28. Schell H., Kiesewetter F., Seidel C., von Hintzenstern J. Cell cycle kinetics of human anagen scalp hair bulbs in thyroid disorders determined by DNA flow cytometry // Dermatologica. – 1991. – 182 (1): 23–26.
  29. Williams R. H. Thyroid and adrenal interrelations with special reference to hypotrichosis axillaries in thyrotoxicosis // J Clin Endocrinol. – 1947. – 7: 52–57
  30. Orfanos C. E., Hertel H. Haarwachstumsstörungen bei Hyperprolaktinämie // Z Hautkr. – 1988. 63: 23–26.
  31. Schmidt J. B. Hormonal basis of male and female androgenic alopecia: clinical relevance // Skin Pharmacol . – 1994. – 7: 61–66.
  32. Lurie R., Ben-Amitai D., Laron Z. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair // Dermatology. – 2004. – 208: 314–318.
  33. Lerner A. B., Case J. D., Takahashi Y. Isolation of melatonin, a pineal factor that lightens melanocytes // J Am Chem Soc. – 1958. – 80: 2 587. 
  34. Karasek M., Reiter R. J. Melatonin and aging // Neuroendocrinol Lett. – 2002; 23 Suppl. 1: 14–6.
  35. Reiter R. J., Tan D. X., Poeggeler B., Menendez-Pelaez A., Chen L. D., Saarela S. Melatonin as a free radical scavenger: implications for aging and age- related diseases // Ann N Y Acad Sci. – 1994. – 719: 1–12.
  36. Slominski A., Fischer T. W., Zmijewski M. A., Wortsman J., Semak I., Zbytek B., et al. On the role of melatonin in skin physiology and pathology // Endocrine. – 2005. – 27: 137–48. 
  37. Tan D. X., Chen L. D., Poeggeler B., Manchester L. C., Reiter R. J. Melatonin: A potent, endogenous hydroxyl radical scavenger // Endocr J. – 1993. – 1: 57–60. 
  38. Fischer T. W., Trüeb R. M., Hänggi G., Innocenti M., Elsner P. Topical Melatonin for Treatment of Androgenetic Alopecia // Int J Trichol. – 2012. – 4: 236–45.
  39. Rossouw J. E., Anderson G. L., Prentice R. L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial // JAMA. – 2002. – 288 (3): 321–333.
  40. Blume-Peytavi U., Kunte C., Krisp A., Garcia Bartels N., Ellwanger U., Hoffmann R. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women // J Dtsch Dermatol Ges. – 2007. – 5 (5): 391–395.
  41. Chein E. Age reversal, from hormones to telomeres // WorldLink Medical Publishing. – 1998.
  42. Fruzetti F. Treatment of hirsutism: antiandrogen and 5a-reductase inhibitor therapy. In: Azziz R, Nestler JE, Dewailly D (eds). Androgen excess disorders in women // Lippincott-Raven, Philadelphia. – 1997. – Р. 787–797.
  43. Hoffmann R., Happle R. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment // Eur J Dermatol. – 2000. – 10: 410–417.
  44. Shapiro J., Kaufman K. D. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss) // J Invest Derm Symp Proc. – 2003. – 8: 20–23.
  45. Kaufman K. D., Olsen E. A., Whiting D., et al. Finasteride in the treatment of men with androgenetic alopecia // J Am Acad Dermatol. – 1998. – 39: 578–589.
  46. Price V. H., Roberts J. L., Hordinsky M., Olsen E. A., Savin R., Bergfeld W., Fiedler V., Lucky A., Whiting D. A., Pappas F., Culbertson J., Kotey P., Meehan A., Waldstreicher J. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia // J Am Acad Dermatol. – 2000. – 43: 768–776. 
  47. Olsen E. A., Hordinsky M., Whiting D., Stough D., Hobbs S., Ellis M. L., Wilson T., Rittmaster R. S., Dutasteride Alopecis Research Team. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride // J Am Acad Dermatol. – 2006. – 55: 1 014–1 023.